The independent source for health policy research, polling, and news.
1,641-1,660 of 1,976 results
As California Attorney General Xavier Becerra cracks down on pharmaceutical companies he said paid competitors to delay generic versions of their drugs, he’s also pushing for legislation that would give his department tools to catch more of them. It’s the first of its kind in the nation.
The Wednesday night event marked the second night in a row for Democratic presidential hopefuls to stake claims on how to fix the health care system.
HHS secretary announces a preliminary plan Wednesday to allow Americans to import certain lower-cost drugs from Canada. Manufacturers were quick to criticize the plan, saying it does not guarantee the safety of drugs coming into the country.
The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients’ care.
A small health center in Goshen, Ind., near the border with Michigan, puts “listening to patients’ stories” first. “The rest is housekeeping.”
Candidates used their varying views on how to achieve universal coverage — whether through Medicare for All or more incremental steps — as a means to differentiate themselves from the field.
Asked to choose between building on the Affordable Care Act and replacing it with a national Medicare for All plan, 55% of Democrats and Democratic-leaning independents said they would expand the existing law, according to a Kaiser Family Foundation poll released Tuesday.
Health officials and AIDS advocates in San Francisco have endorsed a new regimen for PrEP medication: to be taken only immediately before and after sex, thus reducing cost and potential side effects. The standard regimen is one pill a day for an open-ended period.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
After reporting by KHN, NPR and CBS, Fresenius has agreed to waive a Montana man’s huge bill for out-of-network dialysis care.
The drug industry has the biggest lobbying war chest.
Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.
Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus court actions on health issues.
CBS This Morning covers the highest KHN-NPR Bill of the Month yet: more than half a million dollars for just 14 weeks of kidney dialysis in Montana.
Kaiser Health News gives you a user-friendly toolkit to help patients understand some of the ins and outs of medical billing, what to do if you receive a surprise medical bill and things to keep in mind before getting medical care.
He needed the lifesaving treatment — he never expected a half-million-dollar bill for 14 weeks of care.
Patients with Type 2 diabetes are often steered toward medicine or insulin treatment. But with additional support, it’s possible to use diet and exercise to control blood sugar. The rising price of insulin drives patients to lower their dependence on the medicine.
Are physicians asking patients the right questions in order to provide good care? Laser-focused on biomedical symptoms, some doctors miss the psychosocial factors that can be a barrier to good health. In Episode 7 of the podcast, we hear about a creative study that uncovers how some medical errors happen.
Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.
Eighteen years ago, most first responders were not thinking about their future health when they spent hours searching “The Pile” for the remains of terror victims. Today, their illnesses are a slow-moving epidemiological nightmare that has been as difficult for scientists to study as it has been easy for politicians to overlook.
© 2026 KFF